YOU ARE NOW LEAVING LUMAKRAS.COM
You are about to leave the LUMAKRAS.com website and enter a website operated by a third party. Amgen is not responsible for and does not endorse or control the content contained on this third-party website.
That has spread to other parts of the body or cannot be removed by surgery, and whose tumor is KRAS G12C positive, and who have received at least one prior treatment.1
HOW DOES LUMAKRAS® WORK?
- LUMAKRAS® is specifically designed for tumors with the KRAS G12C mutation in non-small cell lung cancer (NSCLC)1
- In tumors with this KRAS mutation, the protein remains mostly in an “on” position, and cells are continuously forced to grow2
- LUMAKRAS® targets the mutated KRAS molecule and locks it in the “off” position. This may prevent tumor cell growth3
If your non-small cell lung cancer is
